Xiangjian Zheng
Lab of Cardiovascular Signaling
Centenary Institute
Xiangjian Zheng has not added Biography.
If you are Xiangjian Zheng and would like to personalize this page please email our Author Liaison for assistance.
AngII induces transient phospholipase D activity in the H295R glomerulosa cell model.
Molecular and cellular endocrinology Aug, 2003 | Pubmed ID: 12943994
Modulation of phospholipase D-mediated phosphatidylglycerol formation by differentiating agents in primary mouse epidermal keratinocytes.
Biochimica et biophysica acta Dec, 2003 | Pubmed ID: 14654225
Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation.
The Journal of investigative dermatology Dec, 2003 | Pubmed ID: 14675200
Phospholipase d signaling and extracellular signal-regulated kinase-1 and -2 phosphorylation (activation) are required for maximal phorbol ester-induced transglutaminase activity, a marker of keratinocyte differentiation.
The Journal of pharmacology and experimental therapeutics Mar, 2005 | Pubmed ID: 15537826
Enrichment of regulatory CD4(+)CD25(+) T cells by inhibition of phospholipase D signaling.
Nature methods Aug, 2006 | Pubmed ID: 16862138
A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid.
The Journal of investigative dermatology Dec, 2007 | Pubmed ID: 17597824
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.
Nature medicine Feb, 2009 | Pubmed ID: 19151727
Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish.
Developmental biology Apr, 2009 | Pubmed ID: 19389349
CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
The Journal of clinical investigation Aug, 2010 | Pubmed ID: 20592472
Aquaporin-3 in keratinocytes and skin: its role and interaction with phospholipase D2.
Archives of biochemistry and biophysics Apr, 2011 | Pubmed ID: 21276418
Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth.
Developmental cell Aug, 2012 | Pubmed ID: 22898778
Cerebral cavernous malformations arise independent of the heart of glass receptor.
Stroke May, 2014 | Pubmed ID: 24643410
The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.
Developmental cell Jan, 2015 | Pubmed ID: 25625206
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Nature Apr, 2016 | Pubmed ID: 27027284
Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Nature 08, 2016 | Pubmed ID: 27281211
Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.
PloS one , 2016 | Pubmed ID: 27513872
A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.
Circulation research Jan, 2017 | Pubmed ID: 27756792
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.
Nature 05, 2017 | Pubmed ID: 28489816
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유